Projects per year
Fingerprint
Dive into the research topics where Paul F. Riska is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 2 Finished
-
-
MYCOBACTERIOPHANGE INTERACTION WITH M TUBERCULOSIS
National Institute of Allergy and Infectious Diseases
7/15/98 → 6/30/04
Project: Research project
-
Anorectal Testing for Mpox Virus Infection in Men Who Have Sex with Men with and without Proctitis
Meyerowitz, E. A., Gendlina, I., Desai, V. J., Grossberg, R., Nair, S. R., Pujar, B., Riska, P. F., Root, H. B., Toro, J., Torres, J. A., Pirofski, L. A. & Zingman, B. S., Mar 1 2023, In: Clinical Infectious Diseases. 76, 5, p. 934-937 4 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
ACTT-4 Study Group, Sep 2022, In: The Lancet Respiratory Medicine. 10, 9, p. 888-899 12 p.Research output: Contribution to journal › Article › peer-review
53 Scopus citations -
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial
ACTT-3 study group members, Dec 2021, In: The Lancet Respiratory Medicine. 9, 12, p. 1365-1376 12 p.Research output: Contribution to journal › Article › peer-review
Open Access86 Scopus citations -
Unexpected case of cryptococcal meningoencephalitis in a patient with long-standing well-controlled HIV infection
Yoon, H. A., Riska, P. F., Jain, R., Morales, C. & Pirofski, L. A., Jun 2021, In: Medical Mycology Case Reports. 32, p. 14-16 3 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Remdesivir for the treatment of COVID-19 — Final report
ACTT-1 Study Group Members, Essential Regulatory Documents Group Team (ERDG Team), DMID CROMS Study Information Office Team (SIO Team), Safety Oversight Committee Support Team (SOCS Team) & DMID CROMS Teleconferencing Team, Nov 5 2020, In: New England Journal of Medicine. 383, 19, p. 1813-1826 14 p.Research output: Contribution to journal › Article › peer-review
Open Access4588 Scopus citations